The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Busse, C. E.
Right arrow Articles by Eichmann, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Busse, C. E.
Right arrow Articles by Eichmann, K.
The Journal of Immunology, 2005, 175: 3067-3074.
Copyright © 2005 by The American Association of Immunologists

The TCR{beta} Enhancer Is Dispensable for the Expression of Rearranged TCR{beta} Genes in Thymic DN2/DN3 Populations but Not at Later Stages

Christian E. Busse, Anna Krotkova1 and Klaus Eichmann2

Department of Cellular Immunology, Max-Planck-Institute of Immunobiology, Freiburg, Germany

The E{beta} enhancer has been shown to be dispensable for germline transcription of nonrearranged TCR{beta} segments but appears to be required for TCR{beta} V to DJ rearrangement. E{beta} dependency of the subsequent expression of VDJ-rearranged TCR{beta} genes in thymic subpopulations has so far not been analyzed. We generated transgenic mice, using a V{beta}8.2D{beta}1J{beta}1.3-rearranged TCR{beta} bacterial artificial chromosome, which lacked E{beta}, and monitored transgene expression by flow cytometry using V{beta}-specific mAbs and an IRES-eGFP reporter. Transgene expression was found in double negative (DN)2 and DN3 but not at later stages of thymopoesis. There was no toxicity associated with the transgene given that apoptosis in DN3, DN4 was not increased, and the number of DN4 cells generated from DN3 cells in reaggregate thymic organ cultures was not diminished. The transgenic TCR{beta} gave rise to a pre-TCR, as suggested by its ability to suppress endogenous TCR{beta} rearrangement, to facilitate {beta}-selection on a TCR{beta}-deficient background and to inhibit {gamma}{delta} T cell lineage development. The results suggest that the V{beta}8.2 promoter is sufficient to drive expression of rearranged TCR{beta} VDJ genes E{beta} independently in DN2/DN3 but not at later stages.




This article has been cited by other articles:


Home page
JEMHome page
T. Egawa, R. E. Tillman, Y. Naoe, I. Taniuchi, and D. R. Littman
The role of the Runx transcription factors in thymocyte differentiation and in homeostasis of naive T cells
J. Exp. Med., August 6, 2007; 204(8): 1945 - 1957.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.